Bloodhound Tracking Device (BTD) announced the launch of Tracker 1™, a covert, next-generation security and tracking platform ...
GSK (GSK) announced that the US Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, for GSK5764227, GSK’227, its B7-H3-targeted antibody-drug conjugate being ...
Breakthrough therapy designation (BTD) is an expedited regulatory pathway designed to accelerate the development of novel therapies that potentially provide substantial clinical benefits, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results